Debt-to-equity of Envoy Medical, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Envoy Medical, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Envoy Medical, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -149%, a 18% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Envoy Medical, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -149% +32% +18% 30 Sep 2025
Q2 2025 -145% +221% +60% 30 Jun 2025
Q1 2025 -151% -23% -18% 31 Mar 2025
Q4 2024 -163% -86% -113% 31 Dec 2024
Q3 2024 -182% -103% -132% 30 Sep 2024
Q2 2024 -366% -301% -469% 30 Jun 2024
Q1 2024 -128% -54% -72% 31 Mar 2024
Q4 2023 -77% +17% +18% 31 Dec 2023
Q3 2023 -79% +8% +9.3% 30 Sep 2023
Q2 2023 -64% +30% +32% 30 Jun 2023
Q1 2023 -75% +24% +24% 31 Mar 2023
Q4 2022 -93% +7.8% +7.7% 31 Dec 2022
Q3 2022 -87% +52% +37% 30 Sep 2022
Q2 2022 -94% 30 Jun 2022
Q1 2022 -99% 31 Mar 2022
Q4 2021 -101% 31 Dec 2021
Q3 2021 -138% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.